<?xml version="1.0" encoding="UTF-8"?>
<ref id="b17-1040710">
 <label>17.</label>
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Thiele</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Kvasnicka</surname>
    <given-names>HM</given-names>
   </name>
   <name>
    <surname>Orazi</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Myeloprolifierative Neoplasms</article-title>. In: 
  <person-group person-group-type="editor">
   <name>
    <surname>Swerdlow</surname>
    <given-names>SH</given-names>
   </name>
   <name>
    <surname>Campo</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Harris</surname>
    <given-names>NL</given-names>
   </name>
   <etal/>
  </person-group>, eds. 
  <source>WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues</source>. 
  <publisher-loc>Lyon</publisher-loc>: 
  <publisher-name>International Agency for Research on Cancer (IARC)</publisher-name>; 
  <year>2017</year>:
  <fpage>585</fpage>.
 </mixed-citation>
</ref>
